Want to Join Our Team?
Learn about Blue Matter's innovative work experiences, enriching development opportunities, team-oriented "People First" culture, and a lot more.
Insights
Access our ever-expanding library of thought leadership resources for strategic leaders and professionals in biopharma. It’s full of useful content addressing industry challenges, best practices, therapeutic markets, innovative ideas, and forward-looking insights.
Featured Whitepaper
Key Success Factors to Building a Best Practice Medical Affairs Organization
Learn More >
Featured Whitepaper
Building Peak Performance Go-to-Market Operations: Capturing the Value of Medical Innovation in a Fast-Changing Landscape
Learn More >
Whitepaper
COVID-19’s Impact on the Mental and Behavioral Health Landscape: Two-Year Blip or Permanent Change?
Blog
COVID-19’s Impact on the Mental and Behavioral Health Landscape: Two-Year Blip or Permanent Change?
Whitepaper
Summary of Blue Matter “Breakfast Club” Meeting No. 6: Customer Engagement in a Post-COVID World
Infographic
Customer Engagement in a Post-COVID World
Whitepaper
The Evolution of Customer Engagement: How Biopharma Leaders Expect to Change Customer Engagement in a Post-COVID-19 World
Blog
Blue Matter “Breakfast Club” Meeting #5: Practical Implications of the COVID-19 Crisis for Biopharma
Whitepaper
Summary of Blue Matter “Breakfast Club” Meeting No. 5: Implications of COVID-19 for Biopharma
Whitepaper
The COVID-19 Challenge: How Pharma Can Adapt and Succeed in the Face of an Uncertain Future
Blog
The COVID-19 Challenge: How Pharma Can Adapt and Succeed in the Face of an Uncertain Future
Blog
Building Peak Performance Go-to-Market Operations: Capturing the Value of Medical Innovation in a Fast-Changing Landscape
Blog
Surveying the Shifting Landscape in European Market Access (Part 1)
Blog
Biotech in the UK: Successful Stakeholder Relations
Blog
Dispatch from MAPS 2024
Blog
The Oncology Market: 2023 Year in Review
Blog
The “Best Practice Organization,” Part 1: What Is It and Why Is It Critical to Success in Today’s Biopharma Industry?
Blog
August 2023 Roundup of HTA Decisions in Three Top European Markets and a Perspective on How to Sustain a High ASMR Score at Reassessment by HAS
